SMTL ID : 5w85.1 (1 other biounit)

CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

monomer

Ligands

1 x 9YS: 6-[(1,3-benzothiazol-6-yl)amino]-4-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino}-N-methylpyridine-3-carboxamide(Non-covalent)

9YS.1: 15 residues within 4Å: Chain A: M.37, G.38, E.39, V.45, A.56, K.58, V.91, Y.107, V.108, Y.109, M.110, P.111, G.113, D.117, L.163 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.45, A:A.56, A:V.91, A:Y.107, A:Y.107, A:L.163 Hydrogen bonds: A:V.108, A:M.110, A:M.110, A:G.113, A:D.117 Water bridges: A:S.114, A:S.173, A:D.174 pi-Stacking: A:Y.107

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bhide, R.S. et al., Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-10-11

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence